0000899243-20-033216.txt : 20201209 0000899243-20-033216.hdr.sgml : 20201209 20201209200009 ACCESSION NUMBER: 0000899243-20-033216 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201207 FILED AS OF DATE: 20201209 DATE AS OF CHANGE: 20201209 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snyder Douglas B. CENTRAL INDEX KEY: 0001754125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35892 FILM NUMBER: 201379118 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE, VISION PARK, HISTON CITY: CAMBRIDGE STATE: X0 ZIP: CB249BZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GW PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001351288 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 BUSINESS PHONE: 44 1223 266800 MAIL ADDRESS: STREET 1: SOVEREIGN HOUSE STREET 2: VISION PARK CITY: HISTON, CAMBRIDGE CB24 9BZ STATE: X0 ZIP: 00000 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-07 0 0001351288 GW PHARMACEUTICALS PLC GWPH 0001754125 Snyder Douglas B. SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB24 9BZ UNITED KINGDOM 0 1 0 0 Chief Legal Officer Ordinary Shares 2020-12-07 4 S 0 4800 10.84 D 22104 D Ordinary Shares 2020-12-07 4 S 0 9444 10.95 D 23660 D Ordinary Shares 2020-12-07 4 S 0 3984 11.02 D 8676 D Ordinary Shares 2020-12-07 4 S 0 5076 11.11 D 3600 D Ordinary Shares 2020-12-07 4 S 0 1200 11.19 D 2400 D Ordinary Shares 2020-12-07 4 S 0 2400 11.30 D 0 D The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2020. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($130.0325 per ADS). These shares were sold in multiple transactions at prices ranging from $129.69 per ADS (or $10.81 per ordinary share) to $130.50 per ADS (or $10.88 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($131.3749 per ADS). These shares were sold in multiple transactions at prices ranging from $130.83 per ADS (or $10.90 per ordinary share) to $131.81 per ADS (or $10.98 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($132.2066 per ADS). These shares were sold in multiple transactions at prices ranging from $131.87 per ADS (or $10.99 per ordinary share) to $132.30 per ADS (or $11.03 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($133.2948 per ADS). These shares were sold in multiple transactions at prices ranging from $132.90 per ADS (or $11.08 per ordinary share) to $133.64 per ADS (or $11.14 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($134.3200 per ADS). These shares were sold in multiple transactions at prices ranging from $134.32 per ADS (or $11.19 per ordinary share) to $134.32 per ADS (or $11.19 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Converted from price per ADS. The price reported in Column 4 is a weighted average price per ordinary share ($135.6500 per ADS). These shares were sold in multiple transactions at prices ranging from $135.65 per ADS (or $11.30 per ordinary share) to $135.65 per ADS (or $11.30 per ordinary share), inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. /s/ Douglas B. Snyder 2020-12-09